The Effect of RSR13, a Synthetic Allosteric Modifier of Hemoglobin, on Brain Tissue pO2 (Measured by Eproximetry) Following Severe Hemorrhagic Shock in Rats
- 1 January 2003
- book chapter
- Published by Springer Nature
- Vol. 530, 319-329
- https://doi.org/10.1007/978-1-4615-0075-9_30
Abstract
RSR13 is a synthetic allosteric modifier of hemoglobin that decreases the oxygen binding affinity of hemoglobin, potentially increasing oxygen availability to hypoxic tissues. Using in vivo EPR to directly measure cortical pO2, we examined whether RSR13 would improve brain tissue pO2 following severe hemorrhagic shock in rats. Hemorrhagic shock was induced by withdrawing blood (2.7–2.8 mL/100 g/15 min). Following a 30 min shock period, resuscitation was performed by infusion with Ringer lactate plus RSR13 (150mg/kg) or saline (control). Following hemorrhage, brain pO2 decreased by about 14 mm Hg in both groups. Following crystalloid resuscitation brain pO2 remained depressed in the control group but returned to the pre-hemorrhage values in the rats that received RSR13. RSR13 immediately increased and maintained the paO2 while controls had a very gradual increase towards pre-hemorrhage values. There was no difference in the blood pressure or heart rate between groups. RSR13 may have useful applications to decrease the effects of acute hemorrhagic hypoxemia by increasing brain oxygenation.Keywords
This publication has 18 references indexed in Scilit:
- Outcome after Hemorrhagic Shock in Trauma PatientsThe Journal of Trauma: Injury, Infection, and Critical Care, 1998
- Effects of a Synthetic Allosteric Modifier of Hemoglobin Oxygen Affinity on Outcome From Global Cerebral Ischemia in the RatStroke, 1998
- Right-Shifting the Oxyhemoglobin Dissociation Curve with RSR13: Effects on High-Energy Phosphates and Myocardial Recovery After Low-Flow IschemiaJournal of Cardiovascular Pharmacology, 1998
- Assessment of cerebral pO2 by EPR oximetry in rodents: effects of anesthesia, ischemia, and breathing gasBrain Research, 1995
- Oxygen tension in a murine tumor: A combined EPR and MRI studyMagnetic Resonance in Medicine, 1993
- Lithium phthalocyanine: a probe for electron paramagnetic resonance oximetry in viable biological systems.Proceedings of the National Academy of Sciences, 1993
- Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in ratsBiochemistry, 1992
- Measurements of pertinent concentrations of oxygenin vivoMagnetic Resonance in Medicine, 1991
- Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agentsJournal of Medicinal Chemistry, 1991
- Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectorsJournal of Medicinal Chemistry, 1991